174 related articles for article (PubMed ID: 37062524)
1. C/EBPβ-LIP mediated activation of the malate-aspartate shuttle sensitizes cells to glycolysis inhibition.
Ackermann T; Zuidhof HR; Müller C; Kortman G; Rutten MGS; Broekhuis MJC; Zaini MA; Hartleben G; Calkhoven CF
Mol Metab; 2023 Jun; 72():101726. PubMed ID: 37062524
[TBL] [Abstract][Full Text] [Related]
2. The malate-aspartate shuttle is important for de novo serine biosynthesis.
Broeks MH; Meijer NWF; Westland D; Bosma M; Gerrits J; German HM; Ciapaite J; van Karnebeek CDM; Wanders RJA; Zwartkruis FJT; Verhoeven-Duif NM; Jans JJM
Cell Rep; 2023 Sep; 42(9):113043. PubMed ID: 37647199
[TBL] [Abstract][Full Text] [Related]
3. A Ca
Pérez-Liébana I; Juaristi I; González-Sánchez P; González-Moreno L; Rial E; Podunavac M; Zakarian A; Molgó J; Vallejo-Illarramendi A; Mosqueira-Martín L; Lopez de Munain A; Pardo B; Satrústegui J; Del Arco A
J Neurosci; 2022 May; 42(19):3879-3895. PubMed ID: 35387872
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
5. Saturation of the mitochondrial NADH shuttles drives aerobic glycolysis in proliferating cells.
Wang Y; Stancliffe E; Fowle-Grider R; Wang R; Wang C; Schwaiger-Haber M; Shriver LP; Patti GJ
Mol Cell; 2022 Sep; 82(17):3270-3283.e9. PubMed ID: 35973426
[TBL] [Abstract][Full Text] [Related]
6. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle.
Barron JT; Gu L; Parrillo JE
J Mol Cell Cardiol; 1998 Aug; 30(8):1571-9. PubMed ID: 9737943
[TBL] [Abstract][Full Text] [Related]
7. The cardioprotective effect of sildenafil is mediated by the activation of malate dehydrogenase and an increase in the malate-aspartate shuttle in cardiomyocytes.
Gevi F; Campolo F; Naro F; Zolla L
Biochem Pharmacol; 2017 Mar; 127():60-70. PubMed ID: 28017777
[TBL] [Abstract][Full Text] [Related]
8. Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis.
Wang C; Chen H; Zhang M; Zhang J; Wei X; Ying W
Cancer Lett; 2016 Aug; 378(1):1-7. PubMed ID: 27157912
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
[TBL] [Abstract][Full Text] [Related]
10. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.
Yang H; Zhou L; Shi Q; Zhao Y; Lin H; Zhang M; Zhao S; Yang Y; Ling ZQ; Guan KL; Xiong Y; Ye D
EMBO J; 2015 Apr; 34(8):1110-25. PubMed ID: 25755250
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and alpha-glycerophosphate shuttles.
Lumeng L; Bremer J; Davis EJ
J Biol Chem; 1976 Jan; 251(2):277-84. PubMed ID: 1245472
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies.
Zhou L; Stanley WC; Saidel GM; Yu X; Cabrera ME
J Physiol; 2005 Dec; 569(Pt 3):925-37. PubMed ID: 16223766
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.
Greenhouse WV; Lehninger AL
Cancer Res; 1977 Nov; 37(11):4173-81. PubMed ID: 198130
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations in Cytosolic Calcium Regulate the Neuronal Malate-Aspartate NADH Shuttle: Implications for Neuronal Energy Metabolism.
Satrústegui J; Bak LK
Neurochem Res; 2015 Dec; 40(12):2425-30. PubMed ID: 26138554
[TBL] [Abstract][Full Text] [Related]
15. Ischemic Neuroprotectant PKCε Restores Mitochondrial Glutamate Oxaloacetate Transaminase in the Neuronal NADH Shuttle after Ischemic Injury.
Xu J; Khoury N; Jackson CW; Escobar I; Stegelmann SD; Dave KR; Perez-Pinzon MA
Transl Stroke Res; 2020 Jun; 11(3):418-432. PubMed ID: 31473978
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
17. Aminooxyacetic acid inhibits the malate-aspartate shuttle in isolated nerve terminals and prevents the mitochondria from utilizing glycolytic substrates.
Kauppinen RA; Sihra TS; Nicholls DG
Biochim Biophys Acta; 1987 Sep; 930(2):173-8. PubMed ID: 3620514
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta.
Hu B; Wu Z; Jin H; Hashimoto N; Liu T; Phan SH
J Immunol; 2004 Oct; 173(7):4661-8. PubMed ID: 15383601
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
[TBL] [Abstract][Full Text] [Related]
20. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway.
Borst P
IUBMB Life; 2020 Nov; 72(11):2241-2259. PubMed ID: 32916028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
